Prevalence of genetic variants of keratins 8 and 18 in patients with drug-induced liver injury

Public Deposited
Analytics

Downloadable Content

Download PDF
Request Version for Screen Reader
Creator
  • Usachov, Valentyn
    • Other Affiliation: University Medical Center Ulm
  • Urban, Thomas J
    • Affiliation: School of Medicine, Institute for Drug Safety Sciences
  • Fontana, Robert J
    • Other Affiliation: University of Michigan Health System
  • Gross, Annika
    • Other Affiliation: University Hospital Aachen
  • Iyer, Sapna
    • Other Affiliation: University of Michigan Medical School
  • Omary, M. B
    • Other Affiliation: University of Michigan Medical School
  • Strnad, Pavel
    • Other Affiliation: University Hospital Aachen
Abstract
  • Abstract Background Keratin 8 and 18 (K8/K18) cytoskeletal proteins protect hepatocytes from undergoing apoptosis and their mutations predispose to adverse outcomes in acute liver failure (ALF). All known K8/K18 variants occur at relatively non-conserved residues and do not cause keratin cytoskeleton reorganization, whereas epidermal keratin-conserved residue mutations disrupt the keratin cytoskeleton and cause severe skin disease. The aim of our study was to identify keratin variants in idiosyncratic drug-induced liver injury (DILI). Methods Genomic DNA was isolated from 800 patients enrolled in an ongoing US multicenter study, with DILI attributed to a wide range of drugs. Specific K8/K18 exonic regions were PCR-amplified and screened by denaturing HPLC followed by DNA sequencing. The functional impact of keratin variants was assessed using cell transfection and immune staining. Results Heterozygous and compound amino acid-altering K8/K18 variants were identified in 86 DILI patients and non-coding variants in 15 subjects. Five novel amino acid-altering (K8 Lys393Arg, K8 Ala351Val, K8 Ala358Val, K8 Ile346Val, K18 Asp89His) and two non-coding variants were observed. Several variants segregated with specific ethnic backgrounds but were found at similar frequencies in DILI subjects and ethnically matched population controls. Notably, variants in highly conserved residues of K8 Lys393Arg (ezetimibe/simvastatin-related) and K18 Asp89His (isoniazid-related) were found in patients with fatal DILI. These novel variants also led to keratin network disruption in transfected cells. Conclusions Novel K8/K18 cytoskeleton-disrupting variants were identified in two patients and segregated with fatal DILI. Other non-cytoskeleton-disrupting keratin variants did not preferentially associate with DILI.
Date of publication
DOI
Identifier
Resource type
  • Article
Rights statement
  • In Copyright
Rights holder
  • Usachov et al.
Journal title
  • BMC Medicine
Journal volume
  • 13
Journal issue
  • 1
Language
  • English
Bibliographic citation
  • BMC Medicine. 2015 Aug 19;13(1):196
Publisher
  • BioMed Central

Relations

Parents:

This work has no parents.

Items

Thumbnail Title Date Uploaded Visibility Actions
file details 12916_2015_article_418.pdf 2019-05-07 Public Download
file details 12916_2015_418_moesm3_esm.pdf 2019-05-07 Public Download
file details 12916_2015_418_moesm2_esm.docx 2019-05-07 Public Download
file details 12916_2015_418_moesm1_esm.pdf 2019-05-07 Public Download